Business / Finance

RSS

Depomed third quarter 2012 revenue increases to $33.3 million

Depomed, Inc. today reported financial results for the quarter and nine months ended September 30, 2012.

5 Nov 2012

Express Scripts reports net income of $391.4 million for third quarter 2012

Express Scripts announced 2012 third quarter net income of $391.4 million, or $0.47 per diluted share. Adjusted earnings per share, as detailed in Table 4 were $1.02 per diluted share for the third quarter.

5 Nov 2012

Affymetrix reports net loss of $17.9 million for third quarter 2012

Affymetrix, Inc., today reported its operating results for the third quarter of 2012. Total revenue for the quarter was $79.6 million, including approximately $17.6 million in revenue from eBioscience during the third quarter of 2012. This compares to total revenue of $64.0 million for the same period of 2011.

5 Nov 2012

Suicide rates in the US have increased sharply since the economic crisis began

Suicide rates in the US have risen sharply since the economic crisis took hold in 2007, warn the authors of Correspondence published Online First in The Lancet.

5 Nov 2012

Humana to acquire Metropolitan Health Networks

Humana Inc. and Metropolitan Health Networks, Inc. today announced that they have entered into a definitive agreement pursuant to which Humana will acquire Metropolitan in a transaction valued at approximately $850 million plus transaction costs.

5 Nov 2012

Health insurance news: Cigna earnings climb, small businesses drop coverage

The Bloomfield, Conn., managed-care company significantly boosted its full-year adjusted earnings guidance after posting better results than Wall Street expected. The company Thursday also announced a restructuring plan that includes reducing the size of its global workforce about 4%, affecting 1,300 workers amid a mix of layoffs and hiring. Cigna continued a streak of "beat and raise" third-quarter reports for large health insurers.

3 Nov 2012

Torchmark closes previously announced purchase of Family Heritage

Torchmark Corporation is pleased to announce that it closed the previously announced purchase of Family Heritage Life Insurance Company of America (Family Heritage), a privately-held supplemental health insurance provider, on November 1, 2012 for approximately $232 million, subject to final post-closing adjustments.

3 Nov 2012

International Bipolar Foundation announces acquisition of National Bipolar Foundation

International Bipolar Foundation (IBPF) is pleased to announce the acquisition of the National Bipolar Foundation (NBF). NBF was founded by F. Marc Kullman in 2005. After being diagnosed in 1997 with Bipolar Disorder, he was determined to become a spokesperson for the disease, with hopes of eradicating the stigma associated with the illness.

3 Nov 2012

University of Cambridge forms new spin-out company to supply hIPSC-derived cells

The potential therapeutic applications of stem cells - such as regenerating damaged tissues or organs - have generated a great deal of interest over the past decade. While these types of applications are exciting, it is a long journey from lab to clinic. The most immediate impact of stem cells on human health will most likely come from their use in the development of new drugs.

3 Nov 2012

New image guided instrumentation for DePuy Synthes Spine’s leading spine systems

DePuy Synthes Spine announced new image guided instrumentation for two of its leading spine systems and has entered into a new partnership agreement with Brainlab, enabling both companies to offer integrated surgical navigation and imaging solutions.

2 Nov 2012

Stakeholders scramble to define starting points for fiscal cliff negotiations

Lawmakers, CEOs, business groups and charities are scrambling to shape the debate over tax and spending policy after the November elections, staking out negotiating positions for what could be a fast-paced brawl.

2 Nov 2012

Teva third quarter 2012 net revenues increase 14% to $5.0 billion

Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended September 30, 2012.

1 Nov 2012

Transformatix Technologies, NCH partner to create BioLinQ

The latest significant biomedical informatics technology is not coming from the biotech industry or a university. In fact, it's coming from a children's hospital.

1 Nov 2012

Watson acquires Actavis

Watson Pharmaceuticals, Inc. today announced that it has completed the acquisition of the Actavis Group for EUR 4.25 billion.

1 Nov 2012

Integra Holdings, a biopharmaceutical holding company, announced by Yissum

Yissum Research and Development Company of the Hebrew University of Jerusalem, the technology transfer company of the Hebrew University, announced today the inception of its subsidiary, Integra Holdings, a holding company focusing on biopharmaceutical companies based on inventions of researchers from the Hebrew University.

31 Oct 2012

Exact Sciences reports total revenues of $1.0 million for third quarter 2012

Exact Sciences Corp. today announced its financial results for the quarter ended Sept. 30, 2012.

30 Oct 2012

Cardinal Health increases quarterly dividend to $0.275 per share

Cardinal Health today announced that its board of directors has approved a 16 percent increase in the company's quarterly dividend to $0.275 per share, or $1.10 per share on an annualized basis.

30 Oct 2012

Cardinal Health fiscal 2013 first-quarter revenue increases 11% to $25.9B

Cardinal Health today reported fiscal year 2013 first-quarter revenue of $25.9 billion and an 11 percent increase in non-GAAP diluted earnings per share (EPS) from continuing operations to $0.81.

30 Oct 2012

Hospice Care of Kansas announces name change

Harden Healthcare, a Texas-based senior healthcare services provider with operations in 14 states, announced today that its subsidiary, Hospice Care of Kansas, will change its name to Harden Hospice Kansas effective immediately.

30 Oct 2012

Tenet exercises option to extend previously announced cash tender offer

Tenet Healthcare Corporation announced today that it has exercised its option to extend its previously announced cash tender offer to purchase any and all of the $216.361 million aggregate principal amount outstanding of its 7.375% Senior Notes due 2013 until 12:00 midnight, New York City time, on October 31, 2012.

30 Oct 2012